Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8NFD5: Variant p.Gly479Ala

AT-rich interactive domain-containing protein 1B
Gene: ARID1B
Feedback?
Variant information Variant position: help 479 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glycine (G) to Alanine (A) at position 479 (G479A, p.Gly479Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help The poly-Gln region is polymorphic and the number of Gln varies in the population (from 17 to 23). Additional information on the polymorphism described.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 479 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2319 The length of the canonical sequence.
Location on the sequence: help GGMMMGPGGGGAASLSKAAA G SAAGGFQRFAGQNQHPSGAT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         GGMMMGPGGGGAASLSKAAAG--SAAGGFQRFAGQNQHPSGAT

Mouse                         GGMMMGPGGGGAASLSKAAAGAAAAAGGFQRFAGQNQHPSG

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 2319 AT-rich interactive domain-containing protein 1B
Modified residue 487 – 487 Asymmetric dimethylarginine



Literature citations
Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability.
Hoyer J.; Ekici A.B.; Endele S.; Popp B.; Zweier C.; Wiesener A.; Wohlleber E.; Dufke A.; Rossier E.; Petsch C.; Zweier M.; Gohring I.; Zink A.M.; Rappold G.; Schrock E.; Wieczorek D.; Riess O.; Engels H.; Rauch A.; Reis A.;
Am. J. Hum. Genet. 90:565-572(2012)
Cited for: INVOLVEMENT IN CSS1; VARIANTS ALA-94 INS; 128-ALA--ALA-130 DEL; HIS-165; SER-329; 401-GLY-GLY-402 DEL; GLY-402 DEL; 410-GLY-GLY-411 DEL; 416-GLY--GLY-420 DEL; VAL-446; ALA-479; VAL-512; PRO-533 INS; ASN-580; THR-614; GLU-959; LEU-1063; ILE-1175; PRO-1332; GLU-1354; ARG-1386; ASN-1404; SER-1494; LYS-1549; HIS-1589; MET-1656; SER-1742; GLU-1816 DEL; ARG-1856; ASN-1934; ARG-1981; ARG-2037 AND ARG-2246;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.